At the Crossroads of Clinical and Preclinical Research for Muscular Dystrophy—Are We Closer to Effective Treatment for Patients?
Among diseases affecting skeletal muscle, muscular dystrophy is one of the most devastating and complex disorders. The term ‘muscular dystrophy’ refers to a heterogeneous group of genetic diseases associated with a primary muscle defect that leads to progressive muscle wasting an...
Main Author: | Kinga I. Gawlik |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2018-05-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | http://www.mdpi.com/1422-0067/19/5/1490 |
Similar Items
-
Therapeutic potential of matrix metalloproteinases in Duchenne muscular dystrophy
by: Yuji eOgura, et al.
Published: (2014-04-01) -
Pathophysiological Mechanisms of Sarcopenia in Aging and in Muscular Dystrophy: a Translational Approach
by: Luciano eMerlini, et al.
Published: (2015-08-01) -
Role of the Ste20 Like Kinase in Muscle Development and Muscular Dystrophy
by: Pryce, Benjamin
Published: (2019) -
Skeletal Muscle Metabolism in Duchenne and Becker Muscular Dystrophy—Implications for Therapies
by: Ahlke Heydemann
Published: (2018-06-01) -
The Failed Clinical Story of Myostatin Inhibitors against Duchenne Muscular Dystrophy: Exploring the Biology behind the Battle
by: Emma Rybalka, et al.
Published: (2020-12-01)